SC
Therapeutic Areas
Stylus Medicine Pipeline
| Drug | Indication | Phase |
|---|---|---|
| In vivo CAR-T Therapy | Oncology (unspecified) | Pre-clinical |
Leadership Team at Stylus Medicine
EN
Emile Nuwaysir, Ph.D.
Chairman & Chief Executive Officer
JF
Jason Fontenot, Ph.D.
Chief Scientific Officer
NH
Nicole Heifner
SVP, Finance & Human Resources
CR
Celeste Richardson, Ph.D.
SVP, Immunology
HC
Hak Chang, Ph.D., J.D.
Vice President, Intellectual Property